In recent years, studies have found that FXR plays an important role in human glucose and lipid metabolism, and its abnormal activation can promote fatty liver, T2DM, dyslipidemia, obesity, and other diseases [23–25]. Here, NR1H4 is linked to Hepatic steatosis.